Clinical trial
Analgesic Efficacy of Multisite rTMS in Depressed and Nondepressed Patients With Fibromyalgia and Prediction of the Response: a Double-Blind Randomized Sham-Controlled Study.
NCT07642882 is registered in ClinicalTrials.gov with Hospital Ambroise Paré Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analgesic Efficacy of Multisite rTMS in Depressed and Nondepressed Patients With Fibromyalgia and Prediction of the Response: a Double-Blind Randomized Sham-Controlled Study.
- Lead sponsor
- Hospital Ambroise Paré Paris
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 30, 2026
- Completion date
- November 30, 2028
- Enrollment
- 36 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic pain, depression - major depressive disorder, fibromyalgia